GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ascendis Health Ltd (JSE:ASC) » Definitions » Inventory Turnover

Ascendis Health (JSE:ASC) Inventory Turnover : 1.16 (As of Jun. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Ascendis Health Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Ascendis Health's Cost of Goods Sold for the six months ended in Jun. 2023 was R466 Mil. Ascendis Health's Average Total Inventories for the quarter that ended in Jun. 2023 was R403 Mil. Ascendis Health's Inventory Turnover for the quarter that ended in Jun. 2023 was 1.16.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Ascendis Health's Days Inventory for the six months ended in Jun. 2023 was 157.86.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ascendis Health's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.53.


Ascendis Health Inventory Turnover Historical Data

The historical data trend for Ascendis Health's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Health Inventory Turnover Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.10 0.87 1.11 2.23 2.52

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 1.44 1.85 1.15 1.16

Ascendis Health Inventory Turnover Calculation

Ascendis Health's Inventory Turnover for the fiscal year that ended in Jun. 2023 is calculated as

Inventory Turnover (A: Jun. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Jun. 2023 ) / ((Total Inventories (A: Jun. 2022 ) + Total Inventories (A: Jun. 2023 )) / count )
=930.906 / ((371.866 + 365.938) / 2 )
=930.906 / 368.902
=2.52

Ascendis Health's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover (Q: Jun. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Jun. 2023 ) / ((Total Inventories (Q: Dec. 2022 ) + Total Inventories (Q: Jun. 2023 )) / count )
=465.587 / ((439.531 + 365.938) / 2 )
=465.587 / 402.7345
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascendis Health  (JSE:ASC) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ascendis Health's Days Inventory for the six months ended in Jun. 2023 is calculated as:

Days Inventory =Average Total Inventories (Q: Jun. 2023 )/Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=402.7345/465.587*365 / 2
=157.86

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ascendis Health's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=402.7345 / 758.223
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Ascendis Health Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Ascendis Health's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Health (JSE:ASC) Business Description

Traded in Other Exchanges
N/A
Address
1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.